GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genome & Co (XKRX:314130) » Definitions » Inventories, Other

Genome (XKRX:314130) Inventories, Other : ₩0 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Genome Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Genome's other inventories for the quarter that ended in Sep. 2024 was ₩0 Mil.

Genome's quarterly other inventories increased from Mar. 2024 (₩0 Mil) to Jun. 2024 (₩0 Mil) but then declined from Jun. 2024 (₩0 Mil) to Sep. 2024 (₩0 Mil).

Genome's annual other inventories declined from Dec. 2021 (₩-0 Mil) to Dec. 2022 (₩-0 Mil) but then increased from Dec. 2022 (₩-0 Mil) to Dec. 2023 (₩0 Mil).


Genome Inventories, Other Historical Data

The historical data trend for Genome's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genome Inventories, Other Chart

Genome Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Other
Get a 7-Day Free Trial - - - - -

Genome Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genome Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Genome Business Description

Traded in Other Exchanges
N/A
Address
Innovalley A-801, Pangyo-ro 253, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486
Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

Genome Headlines

No Headlines